Loading news...
The U.S. cannabis industry continues evolving as 2026 approaches. Growth remains uneven, yet opportunity still exists. Several operators are focusing on efficiency and profitability. Meanwhile, investors are watching for progress on federal reform. Rescheduling discussions has improved overall sentiment. However, capital access remains limited for many companies.
Q4 2025 and FY 2025 revenue expected to be ~$120 million and ~$500 million, respectively Q4 2025 and FY 2025 Adjusted EBITDA projected at ~$30 million and ~$117 million Balance sheet strength with $86 million cash and no significant debt maturities until 2029 Q4 & FY 2025 earnings call scheduled for Thursday, March 12, at 5:00 PM ET NEW YORK, Feb. 9, 2026 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH", "Ascend" or the "Company") (CSE: AAWH-U) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator, today announced preliminary, unaudited results for the fourth quarter and year ended December 31, 2025. For the fourth quarter of 2025 ("Q4 2025"), the Company expects net revenue to be approximately $120 million and Adjusted EBITDA to be approximately $30 million, representing an Adjusted EBITDA margin of ~25%.
AAWH, AYTU and BCAL have been added to the Zacks Rank #5 (Strong Sell) List on February 2, 2026.
AMRN, AMTB and AAWH have been added to the Zacks Rank #5 (Strong Sell) List on January 28th, 2026.
Ascend Wellness Holdings, Inc. (OTC: AAWH - Get Free Report)'s stock price rose 4.6% during trading on Wednesday. The stock traded as high as $0.64 and last traded at $0.64. Approximately 140,212 shares traded hands during trading, an increase of 43% from the average daily volume of 98,209 shares. The stock had previously closed at
Englewood, Ohio dispensary to serve medical patients and non-medical customers NEW YORK, Jan. 14, 2026 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH," "Ascend," or the "Company") (CSE: AAWH.U) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator, today announced the opening of its newest Ohio dispensary located in Englewood, Ohio at 7701 Hoke Road, Englewood, Ohio 45315. The dispensary will begin welcoming medical patients and non-medical customers today, followed by a grand opening on January 16.
2026 could be a big year for marijuana stocks and even bigger for the industry as a whole. By now, most are aware of the rescheduling of cannabis carried out by Donald Trump. From an industry stance, this will change many things, hopefully for the better. That is the thought, anyway, especially with various other measures soon to be voted on. News on reform often triggers a bounce for most cannabis stocks. In fact, finding top cannabis stocks to buy and holding until reform news creates a rise is some traders' strategy.
Much of the talk surrounding marijuana stocks trading better is based on new reform. Right now, many are waiting to see what Donald Trump will do regarding making cannabis a Class 3 substance. This news has set the cannabis sector ablaze. Right now, people are focusing on how to take advantage of this and make a profit. With a new year around the corner, using speculation on reform measures is a strategy some will take towards making a profit.
Marijuana stocks are feeling the boost in trading and all-around preparation for 2026. So far, December 2025 has shown to be a month of possible reform measures being voted on and pushed through. You have Florida pushing a bill to enact home grow, and in recent talks, Donald Trump could very well execute an executive order to reschedule cannabis. If this takes place, this would be a win for some and a loss for others.
Mister Jones Dispensary Set to Open December 19 NEW YORK , Dec. 10, 2025 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH," "Ascend," or the "Company") (CSE: AAWH.U/ OTCQX:AAWH), a multi-state, vertically integrated cannabis operator, has announced a partnership agreement with Mister Jones, LLC and longtime adult-use cannabis advocate Lerone Jones. This partnership marks a significant milestone as it is one of the first under New Jersey's recent Assembly Bill A4151, which facilitates expanded investment opportunities for diversely-owned businesses in the cannabis industry.
The cannabis sector continues to garner attention as investors seek growth opportunities in emerging industries. Although the broader market has experienced volatility, many marijuana companies remain focused on expansion, brand development, and operational efficiency. As a result, some lower-priced cannabis stocks have begun to attract renewed interest. These stocks, often referred to as marijuana penny stocks, can provide significant upside potential when market conditions improve. However, they also involve higher levels of risk, so careful assessment is necessary.
Ascend Wellness Holdings, Inc. (OTCQX:AAWH) Q3 2025 Earnings Call November 10, 2025 5:00 PM EST Company Participants Samuel Brill - CEO & Director Roman Nemchenko - Chief Financial Officer Conference Call Participants Frederico Yokota Gomes - ATB Capital Markets Inc., Research Division Neal Gilmer - Haywood Securities Inc., Research Division Luke Hannan - Canaccord Genuity Corp., Research Division Andrew Semple - Ventum Financial Corp., Research Division Presentation Operator Good afternoon and thank you for standing by. Welcome to the Ascend Wellness Holdings Third Quarter 2025 Earnings Call.
Ascend Wellness Holdings, Inc. (AAWH) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to a loss of $0.13 per share a year ago.
Delivered Q3 2025 Net Revenue of $124.7 million Achieved Q3 2025 Adjusted EBITDA1 of $31.1 million, representing a 24.9% margin Focused margin optimization fueled sequential Adjusted Gross Margin 1 growth of 300-basis points to 46.4% Drove strategic market densification with seven new stores added year-to-date, expanding nationwide footprint to 46 locations2 NEW YORK , Nov. 10, 2025 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH," "Ascend," or the "Company") (CSE: AAWH.U) (OTCQX: AAWH), a leading, multi-state, vertically integrated cannabis operator and consumer packaged goods company, today reported its financial results for the quarter ended September 30, 2025 ("Q3 2025"). Financial results are reported in accordance with U.S. generally accepted accounting principles ("GAAP"), and all currency is in U.S. dollars.
Over the past year, the cannabis industry has undergone another wave of transformation—driven by shifting regulations and growing consumer demand. As well as a renewed investor interest in marijuana stocks. After a period of market correction and consolidation, 2024 into 2025 has shown some signs of stabilization. This has been shown with stronger balance sheets, strategic mergers, and a focus on profitability rather than rapid expansion. As the sector matures, both retail and institutional investors are starting to look beyond short-term volatility. Now people see the potential long-term value in select cannabis stocks poised for growth.
In today's cannabis market, there is much more upside than before. Even with more obstacles to overcome, it's safe to say the legal cannabis worldwide is growing. Between the US and Canada, companies have had to evolve to adjust to new laws and regulatory matters. The ongoing fight for reform in the US cannabis market, along with more states looking to legalize, is seen by investors as a positive development.
When looking for the best marijuana stocks to buy, a strategic game plan is a must. What this would look like in most cases is watching and learning about the sector and the cannabis companies that are traded. Please do your research, learn about them, and see how they have traded and what patterns are made, and how they react in the market. Even in one of the most unpredictable sectors, profits can be made through good strategies.
NEW YORK , Oct. 20, 2025 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH", "Ascend" or the "Company") (CSE: AAWH.U) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator, today announced that it will hold a conference call on Monday, November 10, 2025, at 5:00 PM ET following the release of its third quarter 2025 financial results. The earnings conference call may be accessed by dialing 1-888-699-1199.
The U.S. cannabis industry continues expanding rapidly, driven by legalization efforts and strong consumer demand. According to recent estimates, total legal cannabis sales exceeded $35 billion in 2024, and experts project growth could reach $70 billion by 2030. These numbers show just how fast the sector is maturing despite regulatory hurdles. Meanwhile, headlines about possible federal rescheduling and banking reform have renewed investor optimism across the market.
The U.S. cannabis industry continues to grow despite market challenges. In 2024, legal cannabis sales reached over $28 billion nationwide. Analysts project that sales could exceed $40 billion annually by 2030, driven by the expansion of adult-use markets and strong consumer demand. Recently, U.S. lawmakers have revisited proposals for banking reform, which could provide cannabis companies with improved access to capital. Additionally, discussions about federal rescheduling have created optimism for multi-state operators and smaller penny stock companies alike. Investors are closely watching these developments, as even small policy shifts may significantly affect valuations. Marijuana penny stocks, often more volatile, provide unique opportunities when momentum builds.